Riskpilot← Back to searchSign inGet full accessBeaMedCon AB
ABActiveOrg 5569071870Träkolsvägen 6General medical practice activities · NACE 8621Est. 20122 employees
Revenue 2025
SEK 1,2M
-61% vs 2024
EBITDA margin
-12.4%
-114% vs 2024
Equity ratio
19.0%
Financial strength
Net profit 2025
SEK 2K
-100% vs 2024
| Revenue | SEK 1,2M | -61% |
| EBITDA | SEK -149K | -114% |
| Net profit | SEK 2K | -100% |
| Total assets | SEK 5,2M | -10% |
| Equity | SEK 995K | -29% |
| Employees | 2 | — |
Legal name
BeaMedCon AB
Org number
5569071870
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
18 oktober 2012
Share capital
SEK 50 000
Employees
2 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-08-31
Financial year
January – December
Signatory rights
Firman tecknas var för sig av ledamoten suppleanten
Company purpose
Aktiebolagets verksamhet ska vara att bedriva hälso- och sjukvård jämte därmed förenlig verksamhet.
Address
Träkolsvägen 6
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | 2 369 | 2 597 | 2 607 | 2 163 | 2 688 | 2 842 | 3 084 | 1 205 |
| Staff expenses | — | — | — | — | — | — | — | — | — | — |
| EBITDA | 742 | 720 | 793 | 789 | 1 134 | 468 | 1 066 | 1 053 | 1 085 | −149 |
| Depreciation & amort. | −75 | −102 | −238 | −238 | −238 | −238 | −163 | −112 | −149 | −149 |
| EBIT | 667 | 618 | 555 | 551 | 896 | 230 | 903 | 941 | 936 | −298 |
| Net financials | −14 | −38 | −47 | −51 | −47 | −52 | −48 | −73 | −153 | −116 |
| Profit before tax | 670 | 394 | 348 | 377 | 750 | 276 | 644 | 629 | 675 | 14 |
| Tax | −149 | −87 | −78 | −100 | −163 | −62 | −134 | −136 | −147 | −12 |
| Net profit | 521 | 307 | 270 | 277 | 587 | 214 | 510 | 493 | 528 | 2 |
| Item | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Total assets | 2 537 | 3 753 | 4 038 | 3 973 | 4 285 | 3 988 | 4 165 | 5 489 | 5 826 | 5 244 |
| Equity | 656 | 664 | 633 | 611 | 948 | 912 | 1 172 | 1 265 | 1 392 | 995 |
| Long-term debt | 1 122 | 2 041 | 2 130 | 1 953 | 1 871 | 1 659 | 1 513 | 2 437 | 2 340 | 2 244 |
| Short-term debt | 516 | 620 | 687 | 700 | 658 | 708 | 560 | 629 | 826 | 1 165 |
| Total debt | 1 638 | 2 661 | 2 817 | 2 653 | 2 529 | 2 367 | 2 073 | 3 066 | 3 166 | 3 409 |
EBITDA margin
-12.4%
This company
15.8%
Market median
-178% vs market
20162025
Equity ratio
19.0%
This company
38.2%
Market median
-50% vs market
20162025
Return on equity
0.2%
This company
18.4%
Market median
-99% vs market
20162025
Net profit margin
0.2%
This company
8.1%
Market median
-98% vs market
20162025
Asset turnover
0.23×
This company
1.12×
Market median
-79% vs market
20162025
Debt / equity
4.27×
This company
0.62×
Market median
-589% vs market
20162025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-09-01 – 2025-08-31
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-09-01 – 2024-08-31
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-09-01 – 2023-08-31
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-09-01 – 2022-08-31
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-09-01 – 2021-08-31
- Annual report 2020Filed via Bolagsverket / SCB · Period 2019-09-01 – 2020-08-31
- Annual report 2019Filed via Bolagsverket / SCB · Period 2018-09-01 – 2019-08-31
- Annual report 2018Filed via Bolagsverket / SCB · Period 2017-09-01 – 2018-08-31
- Annual report 2017Filed via Bolagsverket / SCB · Period 2016-09-01 – 2017-08-31
- Annual report 2016Filed via Bolagsverket / SCB · Period 2015-09-01 – 2016-08-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
MD Chief Auditor | Chief Auditor | 2025 | — | — |
HE | Audit | 2022 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Deputy Board Member | 2022 | — | — | |
| Board of Directors | 2022 | — | — |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of BeaMedCon AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Mats Daniel Andersson | Chief Auditor | 0 companies |
| Hans Erik Gunnar Ihrén | Audit | 0 companies |
| Ralf Hubert Saalmüller | Deputy Board Member | 0 companies |
| Beatrice Gertrud Saalmüller | Board of Directors | 0 companies |